Overview

Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Status:
COMPLETED
Trial end date:
2024-06-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics and safety of HD-P023 and coadministration of Teneligliptin and Empagliflozin in healthy adult volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Handok Inc.
Treatments:
3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine
empagliflozin